Arvee Laboratories India Ltd vs Balaji Amines Ltd Stock Comparison
Arvee Laboratories India Ltd vs Balaji Amines Ltd Stock Comparison
Last Updated on: Mar 22, 2026
Key Highlights
The Latest Trading Price of Arvee Laboratories (India) Ltd is ₹ 146.16 as of 20 Mar 15:30
. The P/E Ratio of Arvee Laboratories (India) Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Balaji Amines Ltd changed from 24 on March 2021 to 24.8 on March 2025 . This represents a CAGR of 0.66% over 5 years The Market Cap of Arvee Laboratories (India) Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Balaji Amines Ltd changed from ₹ 5711 crore on March 2021 to ₹ 3911 crore on March 2025 . This represents a CAGR of -7.29% over 5 years The revenue of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Balaji Amines Ltd for the Dec '25 is ₹ 336.29 crore as compare to the Sep '25 revenue of ₹ 347.61 crore. This represent the decline of -3.26% The ebitda of Arvee Laboratories (India) Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Balaji Amines Ltd for the Dec '25 is ₹ 61.67 crore as compare to the Sep '25 ebitda of ₹ 66.87 crore. This represent the decline of -7.78% The net profit of Arvee Laboratories (India) Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0%
The net profit of Balaji Amines Ltd changed from ₹ 45.56 crore to ₹ 30.76 crore over 7 quarters. This represents a CAGR of -20.11%
The Dividend Payout of Arvee Laboratories (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Balaji Amines Ltd changed from 5.59 % on March 2021 to 22.82 % on March 2025 . This represents a CAGR of 32.49% over 5 years .
About Arvee Laboratories (India) Ltd
Arvee Laboratories (India) Limited was incorporated as a Private Limited Company with the name 'Arvee Laboratories (India) Private Limited' on January 27, 2012 in Ahmedabad, Gujarat.
Subsequently, the Company name was changed to Arvee Laboratories (India) Limited upon conversion into a Public Limited Company on September 19, 2017.
Presently, the Company is engaged in manufacturing of specialized chemicals.
Initially, the control & management of the Company was with Mr. Bharat Rasiklal Chokshi, Mr Saumil Bharatbhai Chokshi, Mr. Sudhakarbhai Chhotabhai Patel and Mr. Shalin Bharat Chokshi who were the subscribers to the Memorandum of Association.
Since, April 01, 2013 the control & management was completely taken over by Mr. Shalin Sudhakarbhai Patel and Mr. Shalin Bharat Chokshi.
The Company started construction of its first plant for Thiophene Derivatives in 2013.
About Balaji Amines Ltd
Promoted by the KPR Group of Industries, Balaji Amines Limited (BAL) was incorporated on October 27, 1988.
The Company is a leading Indian manufacturer of ethyl and methyl amines which have various applications in chemical industries.
It is presently engaged in manufacture and sale of Speciality Chemicals, Pharma Excipients, Aliphatic Amines and Derivatives.
Apart from this, it has now diversified into producing derivatives of methyl and ethyl amines, namely, Di-Methyl Amine Hydrochloride (DMA-HCl), Choline Chloride, Di Methyl Acetamide, etc.
At present, the Company supply to various Blue Chip Companies like IDI, Hoechst, Rallis, Ion Exchange, Cheminor Drugs, TTK Pharma, etc.
It has 4 manufacturing facilities, three plants at Tuljapur and Chincholi in Maharashtra and one at Medak, Telangana.
FAQs for the comparison of Arvee Laboratories (India) Ltd and Balaji Amines Ltd
Which company has a larger market capitalization, Arvee Laboratories (India) Ltd or Balaji Amines Ltd?
Market cap of Arvee Laboratories (India) Ltd is 161 Cr while Market cap of Balaji Amines Ltd is 3,459 Cr
What are the key factors driving the stock performance of Arvee Laboratories (India) Ltd and Balaji Amines Ltd?
The stock performance of Arvee Laboratories (India) Ltd and Balaji Amines Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Arvee Laboratories (India) Ltd and Balaji Amines Ltd?
As of March 22, 2026, the Arvee Laboratories (India) Ltd stock price is INR ₹146.16. On the other hand, Balaji Amines Ltd stock price is INR ₹1067.8.
How do dividend payouts of Arvee Laboratories (India) Ltd and Balaji Amines Ltd compare?
To compare the dividend payouts of Arvee Laboratories (India) Ltd and Balaji Amines Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.